Is Pharmadrug Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Pharmadrug Inc (PHRX.CN) is currently classified as NOT HALAL as of June 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Pharmadrug Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Pharmadrug Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Pharmadrug Inc?

Muslim investors may consider investing in Pharmadrug Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Pharmadrug Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Pharmadrug Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Pharmadrug Inc updated?

The Shariah compliance status of Pharmadrug Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Pharmadrug Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Pharmadrug Inc?

You can check the latest Shariah compliance status of Pharmadrug Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

PHRX.CN Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: June 27, 2025

Report Source: 2025 1st Quarter Report

Pharmadrug Inc. Stock Analysis PHRX.CN

Canada N/A Nano Cap Report: Q1, 2025

Pharmadrug, Inc. engages in the research, development, and commercialization of controlled substances and natural medicines such as psychedelics, cannabis and naturally derived approved drugs. The firm is focused on the research, development and commercialization of controlled substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third-party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The company also owns 100% of SecureDose Synthetics Inc. a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.

Key Statistics of Pharmadrug Inc (PHRX.CN)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.02CAD0.02

Today's Open

CAD0.02

Volume

280.14K

P/E Ratio (TTM)

52 Week Range

CAD0.01CAD0.03

Market Cap

1.62M

Avg. Volume

114.34K

Dividend Yield

Financial Metrics & Statements of Pharmadrug Inc (PHRX.CN)

FAQ's for Pharmadrug Inc (PHRX.CN)

According to Musaffa’s Shariah screening methodology, Pharmadrug Inc (PHRX.CN) is currently classified as NOT HALAL as of June 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.